Document is current
Any future updates will be listed below
-
Authors
Mostafaei, Roghayeh
Nachvak, Seyed Mostafa
Saber, Amir
Jalilian, Nazanin
Mahaki, Behzad
Salehi, Mohammad Gharib
Behbood, Leila
Ghorbani, Zahra
Rahimi, Somayeh
-
Clinical Trials BETA
Clinical trials referenced in this document:
irct20231219060466n1 at Iranian Registry of Clinical TrialsDocuments that mention this clinical trial
Pistacia atlantica can improve oxidative status in patients with metabolic dysfunction-associated fatty liver disease
https://doi.org/10.1038/s41598-025-04107-z
- License Information
-
More Information
Article History
Received: 30 January 2025
Accepted: 26 May 2025
First Online: 26 September 2025
Declarations
:
: The authors declare no competing interests.
: This article is taken from student Ph.D. thesis. The trial was given ethical approval by the Ethics Committee of the Deputy of Research and Technology of Kermanshah University of Medical Sciences (ethics approval number: IR.KUMS.REC.1402.442) and registered with the Iranian Clinical Trials Registry (registration number IRCT: IRCT20231219060466N1). Informed consent to participate was obtained from all of the participants in the study.
